Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Hans Jaeger"'
Autor:
Miranda Murray, Federico Pulido, Anthony Mills, Moti Ramgopal, Roger LeBlanc, Hans Jaeger, Viviam Canon, David Dorey, Sandy Griffith, Joseph Mrus, William Spreen, David Margolis
Publikováno v:
HIV Research & Clinical Practice, Vol 20, Iss 4-5, Pp 111-122 (2019)
Background: Long-acting (LA) injectable antiretroviral therapy (ART) is a novel modality currently under development as an alternative to daily oral ART. Objective: The LATTE-2 study (ClinicalTrials.gov identifier NCT02120352) showed that cabotegravi
Externí odkaz:
https://doaj.org/article/f6a3b93b9b2d4775a89b193f0be7bb9a
Autor:
Eva M. Grützner, Tanja Hoffmann, Eva Wolf, Elke Gersbacher, Ashley Neizert, Renate Stirner, Ramona Pauli, Albrecht Ulmer, Jürgen Brust, Johannes R. Bogner, Hans Jaeger, Rika Draenert
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
In untreated HIV infection, the efficacy of T cell responses decreases over the disease course, resulting in disease progression. The reasons for this development are not completely understood. However, immunosuppressive cells are supposedly cruciall
Externí odkaz:
https://doaj.org/article/6a789ef29924477ea815883bcd3e27ab
Autor:
Sebastian Noe, Christine I. Moeckel, Christiane Schwerdtfeger, Celia Oldenbuettel, Hans Jaeger, Eva Wolf, Christoph D. Spinner
Publikováno v:
Interdisciplinary Perspectives on Infectious Diseases, Vol 2018 (2018)
Background. There is still considerable uncertainty in handling vitamin D deficiency in people living with HIV (PLWH), due to a lack of comparative data and the wide range of recommended daily intake. Nondaily supplementation might be preferred in ma
Externí odkaz:
https://doaj.org/article/2edcf55490e34c45858d6bc3cac5f083
Publikováno v:
Infectious Disease Reports, Vol 9, Iss 3 (2017)
Risk factors for bone loss in HIV patients might differ or have a different impact in African descent compared to Caucasian populations. The aim of the paper is to analyze the relevance of risk factors on surrogate markers of bone metabolism in HIV-i
Externí odkaz:
https://doaj.org/article/3c3f23627cde4b9a9b7f9bd3128ba615
Autor:
Olaf Degen, Christoph Mayr, Sebastian Noe, Birgit Mueck, Hans Jaeger, Annamaria Balogh, Nils Postel, Eva Wolf, Martin Obermeier, Ramona Pauli, Axel Baumgarten
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 129:798-802
Introduction HIV infection has become a chronic, well-treatable disease and the focus of caretakers has shifted to diagnosis and treatment of comorbidities. Hypogonadism in elderly men with HIV might be of particular relevance, however, little is kno
Autor:
Miguel García Deltoro, Veerle Van Eygen, Paul D Benn, Kimberly Y. Smith, Hans Jaeger, Parul Patel, Fritz Bredeek, Rodica Van Solingen-Ristea, Christine L. Talarico, William Spreen, Marie-Aude Khuong-Josses, Simon Vanveggel, Susan L. Ford, Gary Richmond, Edgar T. Overton, Giuliano Rizzardini, Krischan J Hudson, Amy Cutrell, Susan Swindells, Vasiliki Chounta, Jaime Andrade-Villanueva, Catherine Orrell, Herta Crauwels, David A. Margolis, Mark S. Shaefer, Firaya Nagimova, Yuanyuan Wang, Alexander Wong
Publikováno v:
The Lancet. 396:1994-2005
Phase 3 clinical studies showed non-inferiority of long-acting intramuscular cabotegravir and rilpivirine dosed every 4 weeks to oral antiretroviral therapy. Important phase 2 results of every 8 weeks dosing, and supportive modelling, underpin furthe
Autor:
Jean-Michel Molina, Kathleen Squires, Paul E Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming-Tain Lai, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar, Peter Sklar, George J Hanna, Carey Hwang, Elizabeth Anne Martin, Debbie P. Hagins, Olayemi O. Osiyemi, David James Prelutsky, Moti N. Ramgopal, Anthony John Scarsella, Robin Dretler, Christopher J. Bettacchi, James Sims, Patrick G. Clay, Nicholaos C. Bellos, Melanie A. Thompson, Jose Montero, Cheryl K. McDonald, Catherine Creticos, David Shamblaw, Miguel Mogyoros, Antonio E. Terrelonge, Martin Valdes, Karen T. Tashima, William J. Robbins, Franco Antonio Felizarta, Richard A. Elion, Jihad Slim, Sandra S. Win, Sujata N. Lalla-Reddy, Peter Jerome Ruane, Anthony Mills, Jerry L. Cade, Craig A. Dietz, David Scott Rubin, Cynthia Mayer, Juan Carlos Rondon, Paul P. Cook, Eric Daar, Princy N. Kumar, Susan Swindells, Jose Guillermo Castro, Ivan Melendez-Rivera, Javier O. Morales-Ramirez, Lizette Santiago, Jorge L. Santana-Bagur, Marcelo Martins, Pedro Enrique Cahn, Gustavo D. Lopardo, Norma Porteiro, Mark Theo Bloch, David Alfred Baker, Norman Roth, Richard James Moore, Robert James Finlayson, James McMahon, Armin Rieger, Alexander Zoufaly, Sylvia Hartl, Robert Zangerle, Fiona Smaill, Sharon L. Walmsley, Brian Conway, Anita Rachlis, Graham H.R. Smith, Carlos Perez, Alejandro Afani, Maria Isabel Campos, Carolina Eugenia Chahin, Marcelo Wolff Reyes, Jan Gerstoft, Nina Weis, Alex Lund Laursen, Yazdan Yazdanpanah, Laurent Cotte, Francois Raffi, Philippe Morlat, Pierre-Marie Girard, Christine Katlama, Juergen K. Rockstroh, Keikawus Arasteh, Stefan Esser, Albrecht Stoehr, Hans-Juergen Stellbrink, Matthias Stoll, Dirk Schuermann, Gerd Faetkenheuer, Johannes Bogner, Thomas Lutz, Axel Baumgarten, Hans Jaeger, Andrea Gori, Gabriel Coltan, Felicia Constandis, Simona Manuela Erscoiu, Liviu-Jany Prisacariu, Sorin Rugina, Adrian Streinu-Cercel, Vadim Valentinovich Pokrovsky, Natalia V. Zakharova, Andrey Anatolyevich Shuldyakov, Elena Pavlovna Ryamova, Valeriy Viktorovich Kulagin, Olga Aleksandrovna Tsybakova, Elena Orlova-Morozova, Firaya Nagimova, Evgeniy Voronin, Tatyana Evgenyevna Shimonova, Oleg Anatolyevich Kozyrev, Catherine Orrell, Johannes Jurgens Lombaard, Marleen de Jager, Joaquin Portilla Segorb, Josep Mallolas, Maria Jesus Perez Elias, Josep M. Gatell, Jose Ramon Arribas Lopez, Eugenia Negredo Puigmal, Daniel Podzamczer Palter, Federico Pulido Ortega, Jesus Troya Garcia, Ignacio De los Santos Gil, Juan Berenguer Berenguer, Ian G. Williams, Margaret A. Johnson, Gabriel Schembri, Amanda Clarke, Mark Gompels, Julie Meriel Fox, Steven John Taylor, David Harold Dockrell, Stephen Kegg
Publikováno v:
The Lancet HIV. 7:e16-e26
Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults with HIV who were treatment naive at week 48 in the phase 3 DRIVE-FORW
Autor:
Sebastian Noe, Celia Jonsson-Oldenbuettel, Hans Jaeger, Veronika Schoenitzer, Annamaria Balogh, Eva Wolf, null Arc HIV study group
Publikováno v:
Current HIV research. 20(3)
Background: Small experimental studies suggest that PTH-secretion following hypocalcemia might be blunted in people living with HIV. Objective: The aim of the study was to estimate the frequency of inadequately low concentrations of parathyroid hormo
Autor:
Anthony Mills, Federico Pulido, Joseph M. Mrus, William Spreen, David Dorey, Viviam Canon, Moti Ramgopal, David A. Margolis, Sandy Griffith, Miranda Murray, Hans Jaeger, Roger LeBlanc
Publikováno v:
HIV Research & Clinical Practice. 20:111-122
Background: Long-acting (LA) injectable antiretroviral therapy (ART) is a novel modality currently under development as an alternative to daily oral ART.Objective: The LATTE-2 study (ClinicalTrials...
Autor:
Hans-Jürgen Stellbrink, Feifan Zhang, Maria Del Mar Masiá, Yazdan Yazdanpanah, Cynthia McCoig, Kati Vandermeulen, Maria Luisa Montes-ramírez, Marty St. Clair, Christopher J Bettacchi, Gary Richmond, Hans Jaeger, David A. Margolis, Kenneth Sutton, Kimberly Y. Smith, Keikawus Arastéh, Rodica Van Solingen-Ristea, Marie-Aude Khuong-Josses, Daniel Podzamczer, Graham H.R. Smith, W Keith Henry, William Spreen
Publikováno v:
Open forum infectious diseases
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Open Forum Infectious Diseases
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Open Forum Infectious Diseases
Background In the Long-Acting Antiretroviral Treatment Enabling Trial 2 (LATTE-2) phase 2b study, long-acting (LA) injectable cabotegravir + rilpivirine dosed every 8 weeks (Q8W) or every 4 weeks (Q4W) demonstrated comparable efficacy with daily oral